Ligand validation:4HPJ

BCN: BICINE

BCN is a Ligand Of Interest in 4HPJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4HPJ_BCN_B_402	60%	56%	0.164	0.951	0.81	0.88	-	-	0	0	100%	1
4HPX_BCN_B_405	83%	42%	0.096	0.956	0.85	1.38	-	1	0	0	100%	1
7KWV_BCN_B_506	79%	58%	0.105	0.95	0.75	0.84	-	-	0	0	100%	1
4HT3_BCN_B_406	75%	53%	0.104	0.938	0.67	1.13	-	-	0	0	100%	1
4HN4_BCN_B_406	73%	59%	0.118	0.946	0.85	0.73	-	-	0	0	100%	1
6WX3_BCN_B_1404	73%	62%	0.117	0.943	0.77	0.69	-	-	0	0	100%	1
5ELB_BCN_A_206	99%	45%	0.045	0.984	0.86	1.25	-	1	0	0	100%	1
2R4J_BCN_B_821	98%	19%	0.061	0.986	1.16	2.25	1	4	2	0	100%	1
5ELE_BCN_D_203	98%	57%	0.052	0.975	0.66	1	-	-	0	0	100%	1
5C7G_BCN_A_201	95%	46%	0.063	0.968	1.07	1.01	-	-	0	0	100%	1
6HMW_BCN_B_205	90%	57%	0.075	0.959	0.74	0.92	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.